Primary study · included by 1 review

Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study.

Eisele 2021 · Eisele Yannick, Mallea Patrick M, Gigic Biljana, et al. · Clinical colorectal cancer · 2021

Included by

Outcome this study informsPooled effectEvidenceCertainty
Overall survival
High intratumoral or fecal Fusobacterium nucleatum load vs Low or no F. nucleatum
HR 1.52 [1.07, 2.16]4 studiesGRADE not reported

1 including review in total.